12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga·04/06/2026 12:05:40
Listen to the news
Gainers
Profusa (NASDAQ:PFSA) stock increased by 126.9% to $1.72 during Monday's pre-market session. The market value of their outstanding shares is at $1.0 million.
Soleno Therapeutics (NASDAQ:SLNO) stock increased by 32.74% to $52.42. The company's market cap stands at $2.1 billion.
PRF Technologies (NASDAQ:PRFX) shares increased by 21.45% to $2.55. The market value of their outstanding shares is at $1.7 million.
Aditxt (NASDAQ:ADTX) stock moved upwards by 15.81% to $0.92.
Annovis Bio (NYSE:ANVS) stock rose 12.92% to $2.57. The company's market cap stands at $64.6 million.
iSpecimen (NASDAQ:ISPC) shares rose 11.46% to $0.16. The company's market cap stands at $1.3 million. As per the press release, Q4 earnings came out 3 days ago.
Losers
Cyclerion Therapeutics (NASDAQ:CYCN) shares decreased by 13.2% to $5.34 during Monday's pre-market session. The market value of their outstanding shares is at $23.4 million.
Imunon (NASDAQ:IMNN) stock fell 11.81% to $2.84. The market value of their outstanding shares is at $10.9 million. The company's, Q4 earnings came out 4 days ago.
Virax Biolabs Group (NASDAQ:VRAX) shares declined by 11.56% to $0.15. The market value of their outstanding shares is at $1.2 million.
Agape ATP (NASDAQ:ATPC) shares fell 11.36% to $2.81. The market value of their outstanding shares is at $3.1 million.
Cocrystal Pharma (NASDAQ:COCP) stock declined by 10.27% to $1.35. The company's market cap stands at $20.8 million. The company's, Q4 earnings came out 4 days ago.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.